Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Vizgen
37 Spinelli Place
Cambridge, MA 02138
https://www.vizgen.com/

Vizgen is a privately held biotech company developing the next generation of spatially resolved, single-cell transcriptomics technology and toolbox. The company's patented MERFISH technology enables massively multiplexed, genome-scale nucleic acid imaging with high accuracy and detection efficiency at subcellular resolution. The high throughput and resolution and the low cost per cell achieved by the technology will enable a wide range of tissue-scale basic research and development and will be instrumental to efforts to discover and map cell types and states in a range of tissues and organisms. Tools employing MERFISH will advance data-driven drug discovery and development and enable new insights for clinical pathology and diagnostics.

Key Contact
Name
Dr. Xiaowei Zhuang
Title
Co-Founder
E-Mail
Funding Events

Date
Amount
Type
Investors
01/30/20 $14,000,000 Series A ARCH Venture Partners
Northpond Ventures
04/07/21 $37,000,000 Series B ARCH Venture Partners
David Walt
Northpond Ventures
Novalis LifeSciences
Pura Vida Investments
Tao Capital Partners